ClinicalTrials.Veeva

Menu

Clinical Evaluation of White Spot Lesions Treated by S-PRG and ICON

A

Al-Azhar University

Status

Invitation-only

Conditions

White Spot Lesion

Treatments

Other: Two composite resin sealants
Other: Giomer

Study type

Interventional

Funder types

Other

Identifiers

NCT05550116
2286488

Details and patient eligibility

About

Randomized with (1:1) prospective, double-blind, controlled trial. Subjects will be randomized to receive S-PRG and the control group receives ICON.

Full description

Interventions: - All the procedures will be performed by the same clinician. DIAGNOdent will be used to assess the fluorescence loss of WSLs and the adjacent sound enamel. WSLs in permanent teeth will be treated according to the manufacturer's instructions with:

  • Group I (Control group): 20 teeth will be treated with ICON.
  • Group II ( EXPERIMENTAL) : 20 teeth will be treated with PRG BarrierCoat.

Observation: - The treatment methods will be assessed immediately after the intervention, 3 months,6 months, and one year. The data will be collected for evaluation of the difference in color and fluorescence loss between the treatment groups, by using DIAGNOdent devices, over different time intervals.

Ethical considerations: The research protocol is approved by the ethical committee, Faculty of Dental Medicine, Al-Azhar University and the enrolled patients should sign a written consent form.

Enrollment

20 estimated patients

Sex

All

Ages

19 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients within 20-40 years of age.
  • Each patient has 4 or more WSLs.
  • Mild and moderate WSLs according to Gorelick's scale.
  • Good oral hygiene and willing patients who can attend the study visits.
  • a Symmetrical number of permanent teeth in each arch (mesial to second molars).

Exclusion criteria

  • Active carious lesions.
  • Facial surface restorations.
  • Intrinsic and extrinsic stains.
  • Patients who have a significant medical history or if they smoke.
  • Criteria for discontinuation; Mortality and acquiring severe debilitating disease

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

20 participants in 4 patient groups

Icon resin infiltration material
Active Comparator group
Description:
Smooth surface resin infiltration comprises three steps for resin infiltration; Icon etch, Icon dry, and Icon infiltrant
Treatment:
Other: Giomer
Other: Two composite resin sealants
PRG Barrier Coat
Experimental group
Description:
fluoride-releasing coating material containing surface reaction-type pre-reacted glass-ionomer (S-PRG) fillers
Treatment:
Other: Two composite resin sealants
Permaseal composite resin sealant
Experimental group
Description:
Permaseal unfilled composite resin sealants
Treatment:
Other: Giomer
Optiguard
Experimental group
Description:
Optiguard unfilled composite resin sealant
Treatment:
Other: Giomer

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems